4 years ago

Somnus Scientific Raises £600K to Advance Safer and Greener Anaesthesia Solutions

  • UK-based anaesthetics innovator Somnus Scientific has secured £600,000 in funding to further develop its products before undertaking testing in the UK

  • The investment round was led by a combination of private investors and a cornerstone institutional investor, Utilico Emerging Markets Trust plc

  • Somnus Scientific's solution aids the transition to the use of propofol as a drug for maintaining anaesthesia by using a world-first biosensor to measure propofol concentration in a patient's bloodstream in real-time.

      • ProblemHealthcare

      "95% of operations worldwide are still performed using anaesthetic gases, which are linked with nausea, slow recovery, memory loss and environmental damage"

      Solution

      "Somnus Scientific's biosensor uses enzymes to metabolise propofol, producing electrons that enable anaesthetists to monitor and adapt sedation levels in real-time, making anaesthesia safer, better for the environment, and more cost-effective"

      Covered on